Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Sarimelati Kencana Tbk. (PZZA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Sarimelati Kencana Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Sarimelati Kencana Tbk. trades at Rp181 (market cap 549.98B, 303.7K 24h volume). The key difference: Sarimelati Kencana Tbk. is the larger of the two by market cap, and Sarimelati Kencana Tbk. is more actively traded (303.7K versus 41.7K). Which is the better fit depends on your goals.
| DGNS | PZZA | |
|---|---|---|
Market Cap | 316.25B | 549.98B |
Volume | 41.7K | 303.7K |
Lot | 417 | 3.04K |
Turnover | 9.66M | 55.19M |
Average Price | 231.65 | 181.72 |
Value | 9.66M | 55.19M |
Indicative Equilibrium Price | 230 | — |
Indicative Equilibrium Volume | 2.4K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Sarimelati Kencana Tbk.
PT Sarimelati Kencana Tbk. (the Company) was established based on Notarial Deed No. 132 dated December 16, 1987 of Lieke Lianadevi Tukgali, S.H.
Read more on PZZA →
